






The addition of probiotic bacteria to the space food system is expected to confer immunostimulatory benefits on crewmembers
during spaceflight, counteracting the immune dysregulation that has been documented in spaceflight [1]. Specifically, the
probiotic Lactobacillus acidophilus has been shown to promote health benefits including antagonism towards and inhibition of
virulence related gene expression in pathogens, mucosal stimulation of immune cells, and a reduction in the occurrence and
duration of cold and flu‐like symptoms [2‐5]. The optimum delivery system for probiotics has not been determined for
spaceflight, where the food system is shelf stable and the lack of refrigeration prevents the use of traditional dairy delivery
methods. This work proposes to determine whether L. acidophilus is more viable, and therefore more likely to confer immune
benefit, when delivered in a capsule form or when delivered in nonfat dry milk powder with a resuscitation opportunity upon
rehydration, following 0, 4, and 8 months of storage at ‐80°C, 4°C, and 22°C, and both prior to and after challenge with
simulated gastric and intestinal juices. We hypothesize that the low moisture neutral dairy matrix provided by the nonfat dry
milk, and the rehydration step prior to consumption, will extend probiotic viability and stress tolerance compared to a capsule






















































































with simulated gastric juice (0.5% wt/vol NaCl containing 3 g/L pepsin, pH 2.0) [6] and enumerated over 2 hours. 3 – Capsule + 
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Initial Data: Shelf Life = 0 Months
Future Work
• This work will be repeated on replicate samples following 4 and 8 months of storage at 22°C.
• Additionally, replicates will be enumerated following 4 and 8 months of storage at ‐80°C and 4°C to indicate the benefit of 
colder temperatures to probiotic provisioning for long duration missions.
• This data will inform provisioning strategies for probiotics, and inform mission planners of storage requirements to 
probiotic survival trade‐offs.
Currently, only the initial analysis (shelf life Time 0) has been completed. All remaining samples are currently in controlled 
storage under described conditions.
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